SLC1A5, solute carrier family 1 member 5, 6510

N. diseases: 81; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.330 Biomarker disease BEFREE We tested inhibitors of ASCT1 and ASCT2 for their effects in rodent models of schizophrenia and visual dysfunction, which had previously been shown to be responsive to d-serine. 30171039 2018
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.330 Biomarker disease BEFREE We concluded that at least one susceptibility locus for schizophrenia may be located within or nearby SLC6A5, whereas SLC1A4, SLC1A5 and SLC6A9 are unlikely to be major susceptibility genes for schizophrenia in the Japanese population. 18638388 2008
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.330 Biomarker disease LHGDN We concluded that at least one susceptibility locus for schizophrenia may be located within or nearby SLC6A5, whereas SLC1A4, SLC1A5 and SLC6A9 are unlikely to be major susceptibility genes for schizophrenia in the Japanese population. 18638388 2008
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.330 GeneticVariation disease BEFREE The SLC1A5 locus is one of a complex family of genes encoding neutral amino acid transporter proteins and the genetic relation between these other loci and schizophrenia has not yet been established. 9034006 1997